熱門資訊> 正文

复星制药以3425万美元的价格出售Nature ' s Sunshine股票

2025-06-26 18:51

Fosun Pharma USA is selling up to 2,854,607 shares of common stock held in Nature’s Sunshine Products (NASDAQ:NATR) at a price of $12.00 per share.
The offering is expected to close on June 27, 2025, subject to customary closing conditions.
As part of the offering, Nature’s Sunshine (NASDAQ:NATR) has agreed with Fosun Pharma that it may purchase up to $15M of the shares of its common stock that are subject to the offering from the underwriters at the public offering price as part of its previously announced share repurchase program.
NATR -2.83% premarket.

More on Nature's Sunshine

Nature's Sunshine Products, Inc. (NATR) Q1 2025 Earnings Call Transcript
Nature's Sunshine Products: Near-Term Weakness But Attractive Entry Point For Long-Term Investors
Nature’s Sunshine Products launches secondary public offering of common stock
Nature’s Sunshine CEO to step down following appointment of successor; reaffirms guidance
Seeking Alpha’s Quant Rating on Nature's Sunshine

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。